BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16166639)

  • 1. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
    Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha.
    Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS
    J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element.
    Sierra OL; Cheng SL; Loewy AP; Charlton-Kachigian N; Towler DA
    J Biol Chem; 2004 Jul; 279(31):32913-23. PubMed ID: 15131132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
    Zayzafoon M; Abdulkadir SA; McDonald JM
    J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
    Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
    J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
    Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
    Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
    Javed A; Barnes GL; Pratap J; Antkowiak T; Gerstenfeld LC; van Wijnen AJ; Stein JL; Lian JB; Stein GS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1454-9. PubMed ID: 15665096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts.
    Teplyuk NM; Zhang Y; Lou Y; Hawse JR; Hassan MQ; Teplyuk VI; Pratap J; Galindo M; Stein JL; Stein GS; Lian JB; van Wijnen AJ
    Mol Endocrinol; 2009 Jun; 23(6):849-61. PubMed ID: 19342447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor snail regulates osteogenic differentiation by repressing Runx2 expression.
    Park SJ; Jung SH; Jogeswar G; Ryoo HM; Yook JI; Choi HS; Rhee Y; Kim CH; Lim SK
    Bone; 2010 Jun; 46(6):1498-507. PubMed ID: 20215006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
    Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
    Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
    Shui C; Spelsberg TC; Riggs BL; Khosla S
    J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).
    Zhang Y; Hassan MQ; Xie RL; Hawse JR; Spelsberg TC; Montecino M; Stein JL; Lian JB; van Wijnen AJ; Stein GS
    J Biol Chem; 2009 Jan; 284(5):3125-3135. PubMed ID: 19017640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
    Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y
    J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
    Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
    J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.